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Accepted 11 April 2011AbstractObjects: Chlamydia (Chlamydia trachomatis) is a common sexually transmitted infection that places a heavy burden on women and neonatal
health. To avoid severe sequelae such as female infertility, ectopic pregnancy, neonatal infection, such as ophthalmitis, and chronic pelvic pain
prompt and appropriate antibiotic treatment seems the best policy in treating this group of patients. However, adequate treatment is not easy
because many factors can interfere with an early and rapid identification of Chlamydia infection, including complicated mixed microflora of the
vagina and cervix, a nonuser-friendly detection system, and the time required for identification, even with the combination of specific complaints
and a high level of clinical alertness. When dealing with a female patient in a point-of-care (POC) clinic, we need to find the best strategy to
provide the most efficient way to detect this infection.
Materials and Methods: Totally five traditional methods and advanced technologies used for the diagnosis of Chlamydia infection in women
were reviewed. A criterion proposed by World Health Organization with an acronym of ASSURED, representing affordable price, high
sensitivity, high specificity, user-friendly design, rapid process, minimal equipment, and delivered-or-not, was used to reexamine these tools if
they are the best tools. A multiplexed microchip-based immunoassay was evaluated as a potential tool. The ASSURED score was compared and
a Chi-square test with a p value less than 0.05 was considered significant.
Results: Traditional methods, such as symptoms approach, microscopic examination, and microorganism culture that have been broadly used
once, are affordable, simple, and equipment-free but their relatively low sensitivity and specificity limit their use as a test of POC setting for
these infected women. On the other hand, advanced technologies, such as antigen detection by immunoassay and nucleic acid amplification tests,
have contributed to major progress in the diagnosis of Chlamydia because of its accuracy, convenience, and time saving. However, nucleic acid
amplification tests are too expensive, so they cannot be accepted as a screening tool in a developing country. The only significant finding with p
value less than 0.01 was achieved when a more sensitive immunoassay system developed successfully as a test of POC setting.
Conclusions: Eventually, advances in laboratory techniques will satisfy our needs to detect Chlamydia infection economically and instantly.
Microarray chips might be a relatively rapid, easy, inexpensive, and sensitive tool to detect many pathogens, including Chlamydia, using a one-
time vaginal sampling process, which might make a POC policy possible.
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Lower genital tract infection in women is the most common
disease in gynecological clinics [1]. Most of these infections are
caused bymixed pathogens. Treatment is frequently neglected or
delayed [2], especially for sexually transmitted infections
(STIs), resulting in subsequent fulminant infection (pelvic
inflammatory diseases) [3]. STIs are also some of the most
commonurgent diseases in the emergency department. Although
intensive treatment is used, some STIs are ultimately compli-
cated with severe sequelae, resultant socioeconomic problems,
infertility, ectopic pregnancy, preterm labor, and chronic pelvic
pain [4]. Therefore, it is important to identify these highly
invasive pathogens accurately and rapidly. Prompt and appro-
priate antibiotic treatment can lead to patients avoiding most of
these complications.
To make an early diagnosis of STIs, familiarity with the
diseases, a high degree of suspicion, and an easy-to-use diag-
nostic method are important. Because of the development of
artificial reproductive techniques and the well-recognized
adverse effects of Chlamydia infection on fertility, the poly-
merase chain reaction method has been used in the diagnosis of
Chlamydia infection for decades. However, the diagnosis of
other STIs is still often ignored because of the lack of a formal
and organized training [5], the lower incidence in the general
population, nonspecific symptoms or signs of infection, and the
rare discomfort of the infectedwomen. Of course, lack of simple,
accurate, and easy-to-use diagnostic methods further attenuates
our attention to these detrimental infections in women.
According to the estimate of the World Health Organization
(WHO) [6], more than 340 million cases of curable STIs occur
annually worldwide, and the sequelae of Chlamydia infection
in women, such as the facilitation of HIV transmission, ocular
infections of the newborn, disseminated infection and infer-
tility, are severe and profound. Nearly blind use of antibiotics
for Chlamydia trachomatis infection enabled resistant strains
to spread widely and rapidly. All of these factors contribute to
the necessity of revisiting Chlamydia infection.
In the general population, the estimated prevalence of
Chlamydia infection is around 1.0e12% [7e9], and it increases
up to 35% in specific high-risk groups [10], such as sex workers
[10], those at low socioeconomic levels [6], or groups with
factors, such as young age, black ethnicity [11], frequent sexual
contacts [12], and cases with some specific symptoms, such as
mucopurulent cervical discharge and lower abdominal pain
[9,12]. Different incidencewill determine the variable screening
power of a diagnostic tool.Table 1
ASSURED scoring system quoted from Huppert et al [15] and modified according
Score Affordable (US$) Sensitivity (%) Specificity (%)
0 >35 <65 <65
1 <35 >65 >65
2 <21 >80 >80
3 <7 >95 >95
E-free¼ equipment-free; U¼ user-friendly.Several methods are used to establish a Chlamydia infection.
These tools will be reexamined and compared according to the
“ASSURED” criteria proposed by the WHO [13] and hopefully
help the physicians revisit this common sexually transmitted
disease and reconsider the necessity of a more suitable diag-
nostic tool to provide a point-of-care (POC) service [14].
ASSURED standards for a POC tool mean affordable price,
high sensitivity, high specificity, user-friendly design, rapid
process, minimal equipment, and delivered-or-not [15].
Material and methods
Totally five traditional methods and advanced technologies
used for the diagnosis of Chlamydia infection in women were
enrolled, including symptoms approach, microscopic exami-
nation, microorganism culture, immunoassay, and nucleic acid
amplification tests (NAATs). The recently published articles
(search terms, including Chlamydia, diagnosis, and tech-
nology) on the PubMed were reviewed. A criterion proposed
by WHO with acronym of “ASSURED” was used to reex-
amine these tools. According to the characteristics of Taiwan’s
gynecologic practice, a scoring system quoted from Huppert
et al [15] was modified and presented in Table 1. The total score
divided by 15 was designed as ASSURED efficiency. The
difference of this value among different tools was evaluated with
Chi-square test (SPSS Version 12.0, SPSS Inc., Chicago, IL,
USA), and a p value less than 0.05 was considered significant.
A potential microchip-based detection system was supposed to
increase the sensitivity and specificity of an immunoassay.
Statistical assessment will include this particular tool.
This detecting system was inspired by the advances in high-
throughput assays and microarray chip fabrication. It also
included the liposomal nanovesicles technique to build up
a signal amplifying system and increase the sensitivity. The
details of this system are simplified and illustrated as Fig. 1. A
liposome composed of outer surface bilayer and inner vesicle
contains several hundred thousand fluorescent dyes, which
amplify the fluorescent signals. On the other hand, antibody
microarray is an excellent tool for multiplex detection of
analytes (Fig. 2). Besides the benefits of high-throughput and
multiplexed immunoassays, the amount of sample can be
minimal.
The preliminary unpublished data from our laboratory show
that the sensitivity limit of this system for Chlamydia antigen
in the laboratory is around 6.0 mg (Fig. 3). The estimated cost
for each chip is US$3, if 200 chips are fabricated at the same
time.to the practice in a developing country
U Rapid (h) Robust E-free Delivered
No >3 No No No
Yes <3 Yes Yes Yes
<0.5
Fig. 1. The structure of the liposomal nanovesicles and detection antibody. (A)
Liposomal nanovesicle: outer bilayer lipid membrane; (B) Detection antibody
conjugated with biotin.
Fig. 2. The detecting procedure of microorganisms by microarray chip and
examples. (A) The detection procedure. (B) Examples of the detecting system
with original antibody and conjugated antibody on glasses showing positive
detection of latter.
Fig. 3. The dose response table for Chlamydia antigen detection.
Ab¼ antibody.
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The application of the revised ASSURED scoring system on
the tools was summarized in Table 2. The affordable item was
modified according to the situation of a developing country. In
Taiwan, the cost of US$7 (NT 200) of an ordinary test was paid
by government insurance (National Health Insurance), but for
those noninsurance patients, US$3 (NT 1000) was requested.
Sensitivity and specificity data from the references are presented
in the Discussion section. User friendly is considered as the
accessibility of training for an ordinary laboratory staff in
Taiwan. Time consumed for the result was within 30minutes like
other ordinary tests in Taiwan or within 3 hours before the cease
of an outpatient section. Robust score depends on the necessity to
freeze and transport the samples. Unfortunately, NAATs for
Chlamydia in Taiwan are almost not robust according to this
definition. Equipment-free here meant the ease of sample
collection. Finally, the delivered-or-not item is determined by
whether it is available in ordinary clinic of Taiwan.
The statistics results of the advanced tools were summa-
rized in Table 3. The only significant difference was identified
between NAATs and the developing immunoassay system
with a p value less than 0.01 when their sensitivity was more
than 85% and specificity more than 95%.
Discussion
To clarify the value and limitation of the recently used tools
for diagnosis of Chlamydia infection in female population, each
tool has been extensively reviewed before the further discussion.Method 1: syndromic approachIn a society with a lower socioeconomic level and limited
laboratory resources, this may be the only possible method for
the diagnosis of cervical infection. This subjective and non-
consistent method depends on thorough surveillance of
various symptoms caused by different and multiple pathogens
in individuals with various physical-medical conditions. It is
Table 2
The results of application of scoring system (as Table 1) on different tools in Chlamydia detection
Tools Affordable (US$) Sensitivity Specificity U Rapid Robust E-free D Total
Syndromic 3 12e83% (0) 43e73% (0) 1 2 1 1 1 9
Gram’s stain 3 30e50% (0) 99e100% (3) 1 2 1 1 1 13
Culture 3 50e60% (0) 93% (2) 1 0 0 1 1 8
NAATs 0 91e100% (3) 98e100% (3) 0 0 0 1 1 8
Immunoassay 2 50e85% (1) 90e95% (2) 1 1 1 1 0 9
Microchip 2 90% (2) 95% (3) 1 1 1 1 1 12
D¼ delivered-or-not; E-free¼ equipment-free; NAATs¼ nucleic acid amplification tests; U¼ user-friendly.
The values inside the parenthesis are the calculated values ranging from 0 (the lowest value) to 3 (the highest value).
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symptoms. Moreover, many victims are totally asymptomatic.
This explains its low sensitivity and specificity.
It is believed that Chlamydia infection is confirmed most
likely if a mucopurulent discharge is present during the vaginal
speculum examination [6]. However, mucopurulent discharge
(nonclear, yellowish discharge from the endocervix), friability
(easy bleeding), or tenderness when the cervix is touched with
a swab, and a positive swab test (yellow discoloration of the
swab when inserted in the endocervix), may predict only 50%
of Chlamydia infection [16].
In different populations, such as patients in a family prac-
tice, a prenatal clinic, or a setting especially for sex workers,
different prevalence determines the fluctuated sensitivity,
specificity, and positive predictive value of various detection
tools [12]. The average sensitivity and specificity rates for an
approach by syndrome are no more than 40% [6].
When using a syndromic approach combined with a scoring
system using risk factors, including age, marital status, dyspar-
eunia, and discolored vaginal discharge, higher sensitivity
(60e80%) and specificity (around 60%) were sporadically
reported in certain groups of patients [12]. Despite the low
sensitivity and specificity, it is still an easy, rapid, and economic
tool for the diagnosis. However, symptoms and signs of vaginal
discharge did not predict cervical infection, and a syndromic
approach failed to identify infected women [14]. Screening tests
based on specific diagnostic techniques for C trachomatis are
necessary because most infected women are asymptomatic [17].Method 2: Gram’s stainThe spreading of samples from the cervix on a glass slide
and staining with dyes seems an inexpensive and convenient
screening method for the diagnosis of infection and malig-
nancy. However, it is not recommended for the diagnosis ofTable 3
The statistical results of ASSURED coefficients
Tools Total score Coefficient
(%)
p
1 2
NAATs 8/15 53 0.60 0.0098
Immunoassay 9/15 60 0.053 0.60
Microchip 12/15 80 0.0098 0.053
ASSURED¼ affordable price, high sensitivity, high specificity, user-friendly
design, rapid process, minimal equipment, and delivered-or-not; NAATs¼
nucleic acid amplification tests.cervical infection by the WHO [6] because of its low detection
rate, even when well-trained technicians are available [6].
Some have tried to raise the detection ability of Gram’s stain by
using the criteria of finding 10 or more polymorphonuclear
leukocytes per high-power field in the Gram’s stain. However,
as an aid to diagnosis, a result with sensitivity less than 50% is
disappointing [18]. This might also indicate the minimal role of
Pap smear in identifying cervical infection.
This method was used to study sexually transmitted
urethritis. It was recommended for patients who are diagnosed
presumptively as having urethritis because it may be the only
objective evidence of urethritis [19]. And adding this method as
an adjunct to the diagnostic tests for urethritis increased the
etiologic diagnoses from 37.5% to 79% [20]. Obviously, this
handy method has a potential but limited use in establishing the
diagnosis of Chlamydia infection.Method 3: cultureCell culture of Chlamydia involves delicate processing
procedures and well-trained personnel. Although it was used
as a standard to be compared with the results of other methods,
such as Gram’s stain [21], immunoassay, or NAATs [22] at
one time, there is growing recognition that the culture is not
100% sensitive and, therefore, is not an acceptable “gold
standard” for assessing newer diagnostic technologies [23].
The sensitivity of this method may achieve a level of
around 80e90% with specialized culture medium and culture
conditions, skilled staff, and at least 72 hours of culture time
[24]. A high level of suspicion in an alert clinician is essential
for choosing the right culture medium and condition, and
a significant improvement in the culture rate can also be
achieved by urgent transport and processing of the specimens
in the laboratory.
Compared with the advanced NAATs, the culture method
might sometimes provide more accurate information when the
NAAT method is targeting a changing gene. Moreover, this is
still the only method that provides information about antimi-
crobial agent susceptibility. As resistant strains become
commoner, high quality culture methods will be needed to
ensure a representative sample for susceptibility tests.Method 4: immunoassayDifferent types of immunoassay kits are used to rapidly
detect Chlamydia infections [15]. These methods include
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Vue [27], and the Chlamydia rapid test [28].
Despite their lower sensitivity of around 50e85%, immu-
noassays, as a rapid POC test, might outperform other standard
tests in populations with high sexual activity, such as sexual
workers and/or in those with low return rates in developing
countries [29]. If treatment can be given at the initial visit, the
possibility of the onward transmission of C trachomatis can be
minimized [28]. Because it is an easy-to-use method with
rapid diagnosis, low cost and no requested microscopy, it
might provide a simple and reliable alternative to NAATs in
the detection of Chlamydia infections [28], especially in
a developing country [22].Method 5: NAATsSo far, NAATs have provided high specificity, around
95e100%, and the best sensitivitydaround 95%dof all
diagnostic methods [22]. There are also consistent data among
different NAATs, such as the strand displacement assay (SDA,
BD ProbeTec C trachomatis/N gonorrhoeae Amplified DNA
Assay, Becton-Dickinson, Sparks, MD, USA) [30], APTIMA
Combo 2 and APTIMA GC assays, ligase chain reaction
(Abbott Laboratories, Abbott Park, IL, USA) [31], and Cobas
Amplicor (Roche) [22]. With their extremely high sensitivity
and specificity, they are considered the “gold standard” for
diagnosis and are good with different samples, such as cervical
swabs from the intrusive speculum examination or urine from
the noninvasive route.
However, there are still some shortcomings with these
methods. They can cross-react with other Chlamydia species
and can be affected by specimen transport conditions. False-
negative reports, compared with culture data, resulting from
some research indicate the variation in the target sequence.
Therefore, confirmation with another NAAT method, which
may double the cost, has been recommended.
Because of their high cost, NAATs are not recommended as
the only tool for screening. The use of a molecular testing
strategy may be cost-effective when it is supplemented with
microscopy and culture to provide prompt treatment and further
microbial susceptibility testing [32]. Actually, NAATs are not
only expensive and complicated but also dependent on highly
trained staff and delicate equipment. These factors all hinder the
wide use of these in developing countries; therefore, they might
not be suitable as a diagnostic method in a POC setting [28].Method 6: multiplexed microchip-based immunoassayAdvances in the fields include high-throughput assays and
microarray chip fabrication [33,34] inspired the development
of this system. It is possible to perform multiple immunoas-
says simultaneously with one minimal vaginal sampling. In
addition, the liposomal nanovesicles technique might build up
a signal amplifying system and increase the sensitivity rate of
immunoassays [35,36].
The liposomal nanovesicles are excellent and easy-to-use
signal carriers in biosense analysis [37,38]. Besides thebenefits of high throughput and multiplexed immunoassays,
the amount of sample can be lowered to dozens of microliters
[34,39,40]. These advantages make the method easier and
more convenient.
STIs involve not only the female reproductive organs but
also the anus and oral cavity; therefore, plenty of different
microorganisms and pathogens are found, including different
kinds of bacteria and viruses from the cervix. In this situation,
it is reasonable and convenient to use a single approach with
a multiplexed method to detect all the common microorgan-
isms in one test, either by culture [41] or targeting on nucleic
acid [42]. For an inflammatory disease caused by various and
multiple pathogens, detecting all with one multiplexed method
is the best policy. A thorough and detailed therapeutic plan can
be useful in eradicating this infection [41,42].
Traditional methods, including syndromic approach, Gram’s
stain, and culture, are affordable, simple, and equipment-free;
therefore, they are acceptable based on scoring system in this
study. In fact, these traditional tools are widely used in the
routine practice, although these tools are not recommended as
the only screening tool in POC setting because of their rela-
tively low sensitivity. We recommended that these traditional
methods might be used as an adjunction role when combined
with other tools.
In contrary, advanced technologies, such as antigen detec-
tion by immunoassay and NAATs, have contributed to major
progress in the diagnosis of Chlamydia with extremely high
sensitivity and specificity. NAATs are actually viewed as the
new gold standard for detection of Chlamydia infection.
Providing other advantages, such as time saving and easy
sampling, NAATs are good candidates for a POC setting.
However, the high cost and complicated equipments hinder
their application in low socioeconomic districts or developing
countries. On the other hand, although immunoassay is much
cheaper and simpler than NAATs, its use as a rapid test is
limited because of their relatively lower sensitivity. A more
sensitive immunoassay system seems to overcome this limi-
tation and fit the demands of a POC setting.
The best strategy for the diagnosis of Chlamydia infection
should be based on an ideal POC tool with results available
within 3 hours, followed by immediate treatment and contact
tracing. This will also efficiently reduce the risk of persistent
infection and onward transmission. To achieve our goal of an
accurate diagnostic method for infectious diseases, such as
Chlamydia or Gonococcus [43], advances in techniques to aid
the detection of pathogens should be encouraged and sup-
ported [15].
NAATs supplemented with microscopy and culture are
considered as a best choice in the ideal setting of a developed
country [32]; because of above mentions, NAATs supplemented
with microscopy and culture were inferior to the immunoassay
methods, according to our POC scoring system. Particularly, in
settings where laboratory facilities are not fully available, such
as in a developing country or in high-risk populations where
return rates are low, rapid tests using immunoassay may be
a more effective way of diagnosing Chlamydia infection [28].
The optimal use in these settings requires the development of
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pensive, high-throughput, nanoscale-sensitive, and multiplexed
detection systemmight be the answer. A clinician will be able to
detect the different pathogens causing cervical and vaginal
infections, including Chlamydia, immediately and accurately
using a microarray-based immunoassay.
A POC setting, using a test that meets the criteria of
ASSURED to provide an immediate diagnosis and to initiate
prompt and appropriate treatment, seems to be our best policy
in facing Chlamydia infection.Acknowledgments
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